JP2007532625A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007532625A5 JP2007532625A5 JP2007507864A JP2007507864A JP2007532625A5 JP 2007532625 A5 JP2007532625 A5 JP 2007532625A5 JP 2007507864 A JP2007507864 A JP 2007507864A JP 2007507864 A JP2007507864 A JP 2007507864A JP 2007532625 A5 JP2007532625 A5 JP 2007532625A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- groups
- aryl
- independently selected
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003118 aryl group Chemical group 0.000 claims 69
- 150000001875 compounds Chemical class 0.000 claims 55
- 229910052799 carbon Inorganic materials 0.000 claims 53
- 229910052739 hydrogen Inorganic materials 0.000 claims 43
- 125000000217 alkyl group Chemical group 0.000 claims 31
- 125000003710 aryl alkyl group Chemical group 0.000 claims 30
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 22
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 20
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 16
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 15
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 15
- 125000000753 cycloalkyl group Chemical group 0.000 claims 15
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 15
- 125000000732 arylene group Chemical group 0.000 claims 14
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 14
- 229910052757 nitrogen Inorganic materials 0.000 claims 14
- 229910052760 oxygen Inorganic materials 0.000 claims 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 13
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 11
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 9
- 125000002947 alkylene group Chemical group 0.000 claims 9
- 125000005549 heteroarylene group Chemical group 0.000 claims 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 125000006587 (C5-C10) heteroarylene group Chemical group 0.000 claims 6
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 125000002993 cycloalkylene group Chemical group 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 4
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 4
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 206010041349 Somnolence Diseases 0.000 claims 2
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 2
- 201000003631 narcolepsy Diseases 0.000 claims 2
- -1 thiol compound Chemical class 0.000 claims 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims 2
- 229940126062 Compound A Drugs 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 206010062519 Poor quality sleep Diseases 0.000 claims 1
- 208000032140 Sleepiness Diseases 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 208000001797 obstructive sleep apnea Diseases 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 208000033914 shift work type circadian rhythm sleep disease Diseases 0.000 claims 1
- 230000037321 sleepiness Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290983A EP1586560A1 (en) | 2004-04-13 | 2004-04-13 | Thio-substituted arylmethanesulfinyl derivatives |
| EP04290983.8 | 2004-04-13 | ||
| US56899104P | 2004-05-07 | 2004-05-07 | |
| US60/568,991 | 2004-05-07 | ||
| US11/104,074 | 2005-04-12 | ||
| US11/104,074 US7297817B2 (en) | 2004-04-13 | 2005-04-12 | Thio-substituted arylmethanesulfinyl derivatives |
| PCT/IB2005/000964 WO2005100310A1 (en) | 2004-04-13 | 2005-04-13 | Thio-substituted arylmethanesulfinyl derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007532625A JP2007532625A (ja) | 2007-11-15 |
| JP2007532625A5 true JP2007532625A5 (enExample) | 2008-06-26 |
| JP4972542B2 JP4972542B2 (ja) | 2012-07-11 |
Family
ID=34964553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007507864A Expired - Fee Related JP4972542B2 (ja) | 2004-04-13 | 2005-04-13 | チオ置換アリールメタンスルフィニル誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7297817B2 (enExample) |
| EP (1) | EP1740535B1 (enExample) |
| JP (1) | JP4972542B2 (enExample) |
| CN (1) | CN1972909B (enExample) |
| AT (1) | ATE524439T1 (enExample) |
| AU (1) | AU2005232961B2 (enExample) |
| CA (1) | CA2562554C (enExample) |
| ES (1) | ES2373667T3 (enExample) |
| MX (1) | MXPA06011779A (enExample) |
| NZ (1) | NZ550583A (enExample) |
| WO (1) | WO2005100310A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7314875B2 (en) * | 2004-04-13 | 2008-01-01 | Cephalon, Inc. | Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| US7449481B2 (en) * | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
| EP1702915A1 (en) * | 2005-03-14 | 2006-09-20 | Cephalon France | Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation |
| CN112500338A (zh) | 2013-03-15 | 2021-03-16 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
| EA202092627A1 (ru) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| CA2989243C (en) | 2014-08-13 | 2023-03-14 | Red Bull Gmbh | Heterocyclic compounds with working memory enhancing activity |
| ES2645483T3 (es) | 2014-08-13 | 2017-12-05 | Red Bull Gmbh | Compuestos heterocíclicos con actividad de mejora de la memoria de trabajo |
| EP3474835B1 (en) | 2016-06-23 | 2023-07-05 | University of Maryland, Baltimore | Non-catalytic substrate-selective p38 -specific mapk inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof |
| CA3122371A1 (en) | 2018-12-07 | 2020-06-11 | University Of Maryland, Baltimore | Non-atp/catalytic site p38 mitogen activated protein kinase inhibitors |
| US11286260B2 (en) | 2020-05-18 | 2022-03-29 | Gen1E Lifesciences Inc. | P38α mitogen-activated protein kinase inhibitors |
| AU2021370893B2 (en) | 2020-10-29 | 2024-03-07 | Gen1E Lifesciences Inc. | Crystalline 5-(dimethylamino) -n- (4-(morpholinomethyl)phenyl) naphthalene-1-sulfonamide di-hydrochloride di-hydrate |
| IL306101A (en) | 2021-03-23 | 2023-11-01 | Gen1E Lifesciences Inc | Naphthyl-mutated p38 alpha mitogen-activated protein kinase inhibitors |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE150366C (enExample) | ||||
| US3689567A (en) | 1966-08-01 | 1972-09-05 | Tsung Ying Shen | Benzyl methyl sulfones and process for preparing same |
| US3950542A (en) * | 1967-02-21 | 1976-04-13 | L'oreal | Cysteamine derivatives for oral treatment of seborrhea |
| US3976694A (en) * | 1973-05-10 | 1976-08-24 | Smithkline Corporation | α-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylphenyl ketones |
| US4006183A (en) * | 1975-07-08 | 1977-02-01 | Sandoz, Inc. | Substituted α-methylsulfinyl-o-toluidines |
| GB1520812A (en) * | 1975-10-02 | 1978-08-09 | Lafon Labor | Benzhydrylsulphinyl derivatives |
| GB1570982A (en) | 1976-03-05 | 1980-07-09 | Shell Int Research | Substituted benzyl ethers and thioethers |
| GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
| GB1600840A (en) | 1978-05-30 | 1981-10-21 | Wellcome Found | Diphenylether derivatives useful as flukicidal agents |
| DE3100387A1 (de) * | 1981-01-09 | 1982-09-02 | Basf Ag, 6700 Ludwigshafen | Substituierte diphenylether, diese enthaltende herbizide und ihre anwendung als herbizide |
| FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
| US4980372A (en) * | 1987-05-11 | 1990-12-25 | Ono Pharmaceutical Co., Ltd. | Benzoylaminophenoxybutanoic acid derivatives |
| ES2063756T3 (es) * | 1987-06-04 | 1995-01-16 | Ono Pharmaceutical Co | Derivados de acido benzoilaminofenoxibutanoico. |
| DE3901706A1 (de) * | 1988-05-17 | 1989-11-30 | Bayer Ag | Halogensubstituierte phenoxybenzyl(thi)ol-derivate |
| JPH02229175A (ja) * | 1989-03-02 | 1990-09-11 | Hokko Chem Ind Co Ltd | 環状アシルヒドロキシルアミン誘導体およびその製法 |
| FR2663225B1 (fr) * | 1990-06-14 | 1994-11-04 | Lafon Labor | Nouvelle utilisation du modafinil. |
| US5563169A (en) * | 1991-09-13 | 1996-10-08 | Sankyo Company, Limited | Tricyclic heterocyclic compound |
| FR2684875B1 (fr) * | 1991-12-13 | 1995-05-24 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique. |
| AU3276793A (en) * | 1991-12-20 | 1993-07-28 | Agouron Pharmaceuticals, Inc. | Antifolate quinazolines |
| FR2697162B1 (fr) * | 1992-10-23 | 1995-01-13 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux. |
| FR2706767B1 (enExample) * | 1993-06-22 | 1995-09-08 | Lafon Labor | |
| FR2707637B1 (fr) * | 1993-06-30 | 1995-10-06 | Lafon Labor | Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique. |
| FR2708201B1 (fr) | 1993-06-30 | 1995-10-20 | Lafon Labor | Utilisation de dérivés d'acétamide pour la fabrication de médicaments. |
| EP0723956B1 (de) * | 1995-01-30 | 1999-10-13 | Hoechst Aktiengesellschaft | Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0752421B1 (en) * | 1995-07-07 | 2005-10-12 | AstraZeneca AB | Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists |
| CA2255856C (en) * | 1996-05-17 | 2008-05-13 | Magainin Pharmaceuticals Inc. | Therapeutic uses for an aminosterol compound |
| JP3608021B2 (ja) * | 1996-09-05 | 2005-01-05 | 参天製薬株式会社 | 新規含硫黄アミノ酸誘導体 |
| US5760246A (en) | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| AU8750298A (en) * | 1997-08-28 | 1999-03-22 | Ono Pharmaceutical Co. Ltd. | Peroxisome proliferator-activated receptor controllers |
| FR2771004B1 (fr) | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| US6506757B1 (en) * | 1998-03-10 | 2003-01-14 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| EP1177187B1 (en) * | 1999-04-28 | 2007-07-25 | Sanofi-Aventis Deutschland GmbH | Di-aryl acid derivatives as ppar receptor ligands |
| US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| US6455588B1 (en) * | 1999-08-20 | 2002-09-24 | Cephalon, Inc. | Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| HN2001000008A (es) * | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
| US6670358B2 (en) | 2000-05-16 | 2003-12-30 | Cephalon, Inc. | Substituted thioacetamides |
| US6492396B2 (en) * | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
| KR101098749B1 (ko) | 2000-07-27 | 2011-12-23 | 테바 파마슈티컬 인더스트리즈 리미티드 | 결정질의 순수한 모다피닐 및 이의 제조 방법 |
| JP2002212177A (ja) * | 2000-11-14 | 2002-07-31 | Takeda Chem Ind Ltd | 脂質代謝改善剤 |
| GB0030710D0 (en) * | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
| KR100965201B1 (ko) * | 2001-06-12 | 2010-06-24 | 웰스테트 테라퓨틱스 코포레이션 | 대사 질환의 치료용 화합물 |
| CN1990469A (zh) * | 2001-06-27 | 2007-07-04 | 史密丝克莱恩比彻姆公司 | 作为二肽酶抑制剂的氟代吡咯烷 |
| WO2004022551A1 (ja) * | 2002-09-06 | 2004-03-18 | Takeda Pharmaceutical Company Limited | フランまたはチオフェン誘導体およびその医薬用途 |
| US7449481B2 (en) | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
| US7423176B2 (en) | 2004-04-13 | 2008-09-09 | Cephalon, Inc. | Bicyclic aromatic sulfinyl derivatives |
| EP1586560A1 (en) | 2004-04-13 | 2005-10-19 | Cephalon, Inc. | Thio-substituted arylmethanesulfinyl derivatives |
| US7314875B2 (en) | 2004-04-13 | 2008-01-01 | Cephalon, Inc. | Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| US7119214B2 (en) | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
-
2005
- 2005-04-12 US US11/104,074 patent/US7297817B2/en not_active Expired - Lifetime
- 2005-04-13 AT AT05718427T patent/ATE524439T1/de not_active IP Right Cessation
- 2005-04-13 NZ NZ550583A patent/NZ550583A/en not_active IP Right Cessation
- 2005-04-13 EP EP05718427A patent/EP1740535B1/en not_active Expired - Lifetime
- 2005-04-13 CN CN2005800194167A patent/CN1972909B/zh not_active Expired - Fee Related
- 2005-04-13 JP JP2007507864A patent/JP4972542B2/ja not_active Expired - Fee Related
- 2005-04-13 WO PCT/IB2005/000964 patent/WO2005100310A1/en not_active Ceased
- 2005-04-13 AU AU2005232961A patent/AU2005232961B2/en not_active Ceased
- 2005-04-13 ES ES05718427T patent/ES2373667T3/es not_active Expired - Lifetime
- 2005-04-13 CA CA2562554A patent/CA2562554C/en not_active Expired - Fee Related
- 2005-04-13 MX MXPA06011779A patent/MXPA06011779A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007532627A5 (enExample) | ||
| JP2007532625A5 (enExample) | ||
| JP2006512301A5 (enExample) | ||
| JP2008511601A5 (enExample) | ||
| JP2008533191A5 (enExample) | ||
| JP2005519932A5 (enExample) | ||
| RU2007105350A (ru) | 3-(гетероарилокси)-2-алкил-1-азабициклоалкильные производные, как лиганды альфа-7-nachr (никотиновых ацетилхолиновых рецепторов), предназначенные для лечения заболеваний центральной нервной системы | |
| FR2669336A1 (fr) | Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| CN1173959C (zh) | 在2 －位携带具有磺酰胺结构或砜结构的取代基的8, 8a －二氢茚并 [1,2－d ]噻唑衍生物、它们的制备方法和它们作为药物的用途 | |
| JP2021509683A (ja) | ピリジルイミダゾベンゾジアゼピンプロピオン酸エステル化合物およびその合成と使用 | |
| CA2240060C (en) | O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same | |
| CN1527823A (zh) | 经氘代的3－哌啶子基苯基·乙基酮以及含化合物的药物组合物 | |
| CN1384827A (zh) | 茚并一,萘并一和苯并环庚二氢噻唑衍生物,它们的制备以及它们作为降低食欲药的用途 | |
| JP2010505759A5 (enExample) | ||
| JP2005526073A5 (enExample) | ||
| JP2007530478A5 (enExample) | ||
| CN1152026C (zh) | 多环的2-氨基二氢噻唑体系、它们的制备方法和它们作为药物的用途 | |
| JP2006516588A5 (enExample) | ||
| JP4209684B2 (ja) | 新しい化合物 | |
| RU2005125635A (ru) | Производные инденонкарбоновых кислот и их применение для лечения и предотвращения диабета и дислипидемии | |
| JP2004506715A5 (enExample) | ||
| JP2008515883A5 (enExample) | ||
| JPWO2022266162A5 (enExample) | ||
| RU2014101999A (ru) | Производные пиперазина, способы их получения и их применение в лечении инсулинорезистентности | |
| JP2001335540A5 (enExample) |